Healthcare | March 11, 2024
LVPEI observes World Glaucoma Week
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Vision loss due to Glaucoma can be prevented if it is detected and treated early
These approvals mark significant progress for Venus Remedies in expanding its market presence
BHL will undertake the development and supply of these molecules
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Subscribe To Our Newsletter & Stay Updated
